Eli Lilly CEO and Ryman Hospitality Exec Chairman Make Notable Insider Buys

Eli Lilly CEO David Ricks purchased 1,632 shares at $644.77 each, totaling $1.05M, while Ryman Hospitality Properties Exec. Chairman Colin Reed bought 8,611 shares at $95.21 each, totaling $819,836. Both purchases were made on Tuesday and Wednesday, respectively, with Eli Lilly trading up 2% and Ryman Hospitality Properties trading off 2.8% on Thursday.

Eli Lilly (LLY) CEO David Ricks purchased 1,632 shares at $644.77 each, totaling $1.05 million, on August 12, 2025 [1]. This move followed a 14% stock decline after the company's oral obesity drug, orforglipron, underperformed in Phase 3 trials. The stock purchase comes with LLY trading at $652.91 per share, down 33% from its 52-week high of $952.73 [1]. Ricks' confidence in the company's long-term strategy signals a vote of confidence in Eli Lilly's GLP-1 therapy expansion [1].

Ryman Hospitality Properties (RHP) Executive Chairman Colin Reed bought 8,611 shares at $95.21 each, totaling $819,836, on August 13, 2025 [3]. The $6.1 billion hospitality REIT maintains a GREAT financial health score according to InvestingPro analysis, with a notable 4.85% dividend yield [3]. The purchase increases Reed's direct holdings to 879,017 shares [3].

Both purchases were made on Tuesday and Wednesday, respectively, with Eli Lilly trading up 2% and Ryman Hospitality Properties trading off 2.8% on Thursday.

References:
[1] https://www.tipranks.com/news/eli-lilly-lly-ceo-buys-1-million-of-company-stock-after-recent-crash
[2] https://www.ainvest.com/news/ceo-buy-ins-contrarian-indicator-eli-lilly-ricks-signals-resilience-obesity-drug-markets-2508/
[3] https://www.investing.com/news/insider-trading-news/ryman-hospitality-exec-reed-buys-819k-in-stock-93CH-4189731